(Q44715956)

English

DA-8159, a new PDE5 inhibitor, attenuates the development of compensatory right ventricular hypertrophy in a rat model of pulmonary hypertension

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

DA-8159, a new PDE5 inhibitor, attenuates the development of compensatory right ventricular hypertrophy in a rat model of pulmonary hypertension (English)

1 reference

Europe PubMed Central

5 December 2017

right ventricular hypertrophy

1 reference

based on heuristic

inferred from title

author name string

K K Kang

1

1 reference

Europe PubMed Central

5 December 2017

G J Ahn

2

1 reference

Europe PubMed Central

5 December 2017

Y S Sohn

3

1 reference

Europe PubMed Central

5 December 2017

B O Ahn

4

1 reference

Europe PubMed Central

5 December 2017

W B Kim

5

1 reference

Europe PubMed Central

5 December 2017

publication date

1 November 2003

1 reference

Europe PubMed Central

5 December 2017

Journal of International Medical Research

1 reference

Europe PubMed Central

5 December 2017

31

1 reference

Europe PubMed Central

5 December 2017

6

1 reference

Europe PubMed Central

5 December 2017

517-528

1 reference

Europe PubMed Central

5 December 2017

Primary pulmonary hypertension. A national prospective study

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Inhaled nitric oxide: clinical applications, indications, and toxicology.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Sildenafil inhibits hypoxia-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Cyclic nucleotide phosphodiesterases and vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Hypoxic pulmonary hypertension: its modification by dipyridamole.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation.

1 reference

https://api.crossref.org/works/10.1177%2F147323000303100608

21 January 2018

Identifiers

10.1177/147323000303100608

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44715956&oldid=2098910771"